The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Parthenolide: from plant shoots to cancer roots
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of cells initiating human melanomas
Schatton, T., Murphy, G. F., Frank, N. Y., Yamaura, K., Waaga-Gasser, A. M., Gasser, M., Zhan, Q., Jordan, S., Duncan, L. M., Weishaupt, C., et al. (2008) · Nature · doi:10.1038/nature06489 · Cited by 1,415
Epigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143
Cancer stem cell definitions and terminology: the devil is in the details
Valent, P., Bonnet, D., De Maria, R., Lapidot, T., Copland, M., Melo, J. V., Chomienne, C., Ishikawa, F., Schuringa, J. J., Stassi, G., et al. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3368 · Cited by 692
Guzman, M. L., Rossi, R. M., Karnischky, L., Li, X., Peterson, D. R., Howard, D. S., & Jordan, C. T. (2005) · Blood · doi:10.1182/blood-2004-10-4135 · Cited by 678
What made sesquiterpene lactones reach cancer clinical trials?
Ghantous, A., Gali-Muhtasib, H., Vuorela, H., Saliba, N. A., & Darwiche, N. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.06.002 · Cited by 615
Self-citationKwok, B. H. B., Koh, B., Ndubuisi, M. I., Elofsson, M., & Crews, C. M. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00049-7 · Cited by 515
Cysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by Sesquiterpene Lactones
Garcı́a-Piñeres, A. J., Castro, V., Mora, G., Schmidt, T. J., Strunck, E., Pahl, H. L., & Merfort, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101985200 · Cited by 407
Guzman, M. L., Rossi, R. M., Neelakantan, S., Li, X., Corbett, C. A., Hassane, D. C., Becker, M. W., Bennett, J. M., Sullivan, E., Lachowicz, J. L., et al. (2007) · Blood · doi:10.1182/blood-2007-05-090621 · Cited by 403
Hehner, S. P., Hofmann, T. G., Dröge, W., & Schmitz, M. L. (1999) · PubMed · Cited by 386
Anti-Cancer Potential of Sesquiterpene Lactones: Bioactivity and Molecular Mechanisms
Zhang, S., Won, Y.-K., Ong, C.-N., & Shen, H.-M. (2005) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011053765976 · Cited by 383
Signaling Pathways in Cancer and Embryonic Stem Cells
Dreesen, O., & Brivanlou, A. H. (2007) · Stem Cell Reviews · doi:10.1007/s12015-007-0004-8 · Cited by 357
Hehner, S. P., Hofmann, T. G., Dröge, W., & Schmitz, M. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5617 · Cited by 355
Bork, P. M., Schmitz, M. L., Kuhnt, M., Escher, C., & Heinrich, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01502-5 · Cited by 327
Reactive Oxygen Species in Cancer Stem Cells
Shi, X., Zhang, Y., Zheng, J., & Pan, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4529 · Cited by 325
Perspectives on Sesquiterpene Lactones in Inflammation and Cancer
Merfort, I. (2011) · Current Drug Targets · doi:10.2174/138945011798109437 · Cited by 262
Mathema, V. B., Koh, Y.-S., Thakuri, B. C., & Sillanpää, M. (2012) · Inflammation · doi:10.1007/s10753-011-9346-0 · Cited by 250
Siedle, B., García-Piñeres, A. J., Murillo, R., Schulte-Mönting, J., Castro, V., Rüngeler, P., Klaas, C. A., Da Costa, F. B., Kisiel, W., & Merfort, I. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049937r · Cited by 248
Birnie, R., Bryce, S. D., Roome, C., Dussupt, V., Droop, A., Lang, S. H., Berry, P. A., Hyde, C. F., Lewis, J. L., Stower, M. J., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-5-r83 · Cited by 212
Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide
Orofino Kreuger, M. R., Grootjans, S., Biavatti, M. W., Vandenabeele, P., & D’Herde, K. (2012) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328356cad9 · Cited by 206
NF-κB pathway inhibitors preferentially inhibit breast cancer stem-like cells
Zhou, J., Zhang, H., Gu, P., Bai, J., Margolick, J. B., & Zhang, Y. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9798-y · Cited by 201
Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-κB inhibitor, DMAPT (LC-1)
Neelakantan, S., Nasim, S., Guzman, M. L., Jordan, C. T., & Crooks, P. A. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.092 · Cited by 192
Hassane, D. C., Guzman, M. L., Corbett, C., Li, X., Abboud, R., Young, F., Liesveld, J. L., Carroll, M., & Jordan, C. T. (2008) · Blood · doi:10.1182/blood-2007-11-126003 · Cited by 185
Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways
Dey, A., Tergaonkar, V., & Lane, D. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2759 · Cited by 169
Sweeney, C. J., Mehrotra, S., Sadaria, M. R., Kumar, S., Shortle, N. H., Roman, Y., Sheridan, C., Campbell, R. A., Murry, D. J., Badve, S., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0030 · Cited by 158
Modulation of DNA Methylation by a Sesquiterpene Lactone Parthenolide
Liu, Z., Liu, S., Xie, Z., Pavlovicz, R. E., Wu, J., Chen, P., Aimiuwu, J., Pang, J., Bhasin, D. K., Neviani, P., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147934 · Cited by 157
Optimization of Activity-Based Probes for Proteomic Profiling of Histone Deacetylase Complexes
Salisbury, C. M., & Cravatt, B. F. (2008) · Journal of the American Chemical Society · doi:10.1021/ja074138u · Cited by 143
Parthenolide Inhibits Tubulin Carboxypeptidase Activity
Fonrose, X., Ausseil, F., Soleilhac, E., Masson, V., David, B., Pouny, I., Cintrat, J., Rousseau, B., Barette, C., Massiot, G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3732 · Cited by 128
Liu, Y., Lü, W.-L., Guo, J., Du, J., Li, T., Wu, J., Wang, G., Wang, J., Zhang, X., & Zhang, Q. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.022 · Cited by 121
Gopal, Y. N. V., Arora, T. S., & Dyke, M. W. V. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.06.007 · Cited by 120
Idris, A. I., Libouban, H., Nyangoga, H., Landao‐Bassonga, E., Chappard, D., & Ralston, S. H. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0133 · Cited by 112
Kawasaki, B. T., Hurt, E. M., Kalathur, M., Duhagon, M. A., Milner, J. A., Kim, Y. S., & Farrar, W. L. (2009) · The Prostate · doi:10.1002/pros.20931 · Cited by 102
Antileukemic activity of aminoparthenolide analogs
Nasim, S., & Crooks, P. A. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.050 · Cited by 99
Ivanenkov, Y. A., Balakin, K. V., & Lavrovsky, Y. (2010) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711793564079 · Cited by 97
Tanaka, K., Hasegawa, J., Asamitsu, K., & Okamoto, T. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088674 · Cited by 96
Lesiak, K., Koprowska, K., Zaleśna, I., Nejc, D., Düchler, M., & Czyż, M. (2010) · Melanoma Research · doi:10.1097/cmr.0b013e328333bbe4 · Cited by 93
Cancer stem cells: Models, mechanisms and implications for improved treatment
Zhou, J., & Zhang, Y. (2008) · Cell Cycle · doi:10.4161/cc.7.10.5953 · Cited by 92
Oka, D., Nishimura, K., Shiba, M., Nakai, Y., Arai, Y., Nakayama, M., Takayama, H., Inoue, H., Okuyama, Ä., & Nonomura, N. (2007) · International Journal of Cancer · doi:10.1002/ijc.22570 · Cited by 89
NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
Uchibori, R., Tsukahara, T., Mizuguchi, H., Saga, Y., Urabe, M., Mizukami, H., Kume, A., & Ozawa, K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0088 · Cited by 86
Gunn, E. J., Williams, J. T., Huynh, D. T., Iannotti, M. J., Han, C., Barrios, F. J., Kendall, S. E., Glackin, C. A., Colby, D. A., & Kirshner, J. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.555891 · Cited by 84
Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells.
Pająk, B., Gajkowska, B., & Orzechowski, A. (2008) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-008-0019-2 · Cited by 83
Hassane, D. C., Sen, S., Minhajuddin, M., Rossi, R. M., Corbett, C. A., Balys, M. M., Wei, L., Crooks, P. A., Guzmán, M. L., & Jordan, C. T. (2010) · Blood · doi:10.1182/blood-2010-04-278044 · Cited by 78
Shanmugam, R., Kusumanchi, P., Appaiah, H. N., Liang Cheng, C., Crooks, P. A., Neelakantan, S., Peat, T. J., Klaunig, J. E., Matthews, W., Nakshatri, H., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25587 · Cited by 76
Kishida, Y., Yoshikawa, H., & Myoui, A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1559 · Cited by 75
Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms
Won, Y.-K., Ong, C. N., Shi, X., & Shen, H. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh151 · Cited by 74
Sohma, I., Fujiwara, Y., Sugita, Y., Yoshioka, A., Shirakawa, M., Moon, J., Takiguchi, S., Miyata, H., Yamasaki, M., Mori, M., et al. (2011) · PubMed · Cited by 72
Zhang, D., Qiu, L., Jin, X., Guo, Z., & Guo, C. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0410 · Cited by 71
Nakabayashi, H., & Shimizu, K. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-453 · Cited by 70
Shanmugam, R., Kusumanchi, P., Liang Cheng, C., Crooks, P. A., Neelakantan, S., Matthews, W., Nakshatri, H., & Sweeney, C. J. (2010) · The Prostate · doi:10.1002/pros.21141 · Cited by 67
Tumor Inhibitory Agent from Magnolia grandiflora (Magnoliaceae) I: Parthenolide
Wiedhopf, R. M., Young, M., Bianchi, E., & Cole, J. R. (1973) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600620244 · Cited by 64
Skalska, J., Brookes, P. S., Nadtochiy, S. M., Hilchey, S. P., Jordan, C. T., Guzmán, M. L., Maggirwar, S. B., Briehl, M. M., & Bernstein, S. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008115 · Cited by 62
Targeting Radioresistant Osteosarcoma Cells With Parthenolide
Zuch, D. T., Giang, A., Shapovalov, Y., Schwarz, E. M., Rosier, R. N., O’Keefe, R. J., & Eliseev, R. A. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24002 · Cited by 59
Shanmugam, R., Jayaprakasan, V., Gökmen‐Polar, Y., Kelich, S. L., Miller, K. D., Yip-Schneider, M., Liang Cheng, C., Bhat‐Nakshatri, P., Sledge, G. W., Nakshatri, H., et al. (2006) · The Prostate · doi:10.1002/pros.20482 · Cited by 56
Epigenetic mechanisms of plant-derived anticancer drugs
Schneider‐Stock, R., Ghantous, A., Bajbouj, K., Saikali, M., & Darwiche, N. (2011) · Frontiers in bioscience · doi:10.2741/3919 · Cited by 50
Self-citationDiamanti, P., Cox, C. V., Moppett, J. P., & Blair, A. (2012) · Blood · doi:10.1182/blood-2012-08-448852 · Cited by 49
Melampomagnolide B: A new antileukemic sesquiterpene
Nasim, S., Pei, S., Hagen, F. K., Jordan, C. T., & Crooks, P. A. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.12.045 · Cited by 47
Kim, Y. R., Eom, J.-I., Kim, S., Jeung, H. K., Cheong, J., Kim, J. S., & Min, Y. H. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.169367 · Cited by 43
A Novel Combination Therapy With Arsenic Trioxide and Parthenolide Against Pancreatic Cancer Cells
Wang, W., Adachi, M., Zhang, R., Zhou, J., & Zhu, D. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181a0b6f2 · Cited by 43
Kim, S., Trang, K. T. T., Kim, S., Kim, I. H., Lee, S. O., Lee, S. T., Kim, D. G., & Kim, S. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1587 · Cited by 40
Yip-Schneider, M., Wu, H., Ralstin, M. C., Yiannoutsos, C. T., Crooks, P. A., Neelakantan, S., Noble, S., Nakshatri, H., Sweeney, C. J., & Schmidt, C. M. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0794 · Cited by 40
Kim, I. H., Kim, S. W., Kim, S., Lee, S. O., Lee, S. T., Kim, D. G., Lee, M. J., & Park, W. H. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.7.051 · Cited by 38
Yip-Schneider, M., Wu, H., Njoku, V., Ralstin, M. C., Holcomb, B. K., Crooks, P. A., Neelakantan, S., Sweeney, C. J., & Schmidt, C. M. (2008) · Pancreas · doi:10.1097/mpa.0b013e318172b4dd · Cited by 29
Inhibition of Tumor Promotion by Parthenolide: Epigenetic Modulation of p21
Ghantous, A., Saikali, M., Rau, T. T., Gali‐Muhtasib, H. U., Schneider‐Stock, R., & Darwiche, N. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0230 · Cited by 29
Self-citationTaguchi, T., Takao, T., Iwasaki, Y., Nishiyama, M., Asaba, K., & Hashimoto, K. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06418 · Cited by 23
How close are we to targeting the leukemia stem cell?
Pei, S., & Jordan, C. T. (2012) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2012.10.003 · Cited by 22
Drugs that Kill Cancer Stem-like Cells
Zobalová, R., Stantic, M., Stapelberg, M., Prokopová, K., Dong, L., Truksa, J., & Neužil, J. (2011) · InTech eBooks · doi:10.5772/13588 · Cited by 6
Cited by
Ding, Y., Chen, X., Liu, C., Ge, W., Wang, Q., Hao, X., Wang, M., Chen, Y., & Zhang, Q. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01016-8 · Cited by 415
Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis
Gali-Muhtasib, H., Hmadi, R., Kareh, M., Tohme, R., & Darwiche, N. (2015) · Apoptosis · doi:10.1007/s10495-015-1169-2 · Cited by 293
Self-citationTherapeutic Potential of Certain Terpenoids as Anticancer Agents: A Scoping Review
Kamran, S., Sinniah, A., Abdulghani, M. A. M., & Alshawsh, M. A. (2022) · Cancers · doi:10.3390/cancers14051100 · Cited by 259
Small molecules regulating reactive oxygen species homeostasis for cancer therapy
Zhang, J., Duan, D., Song, Z., Liu, T., Hou, Y., & Fang, J. (2021) · Medicinal Research Reviews · doi:10.1002/med.21734 · Cited by 184
Khalil, M. N. A., Choucry, M. A., El Senousy, A. S., Hassan, A., El-Marasy, S. A., El Awdan, S. A., & Omar, F. A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0219378 · Cited by 25
Metadata
- Authors
- Ghantous, A., Sinjab, A., Herceg, Z., & Darwiche, N.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 18
- Issue
- 17-18
- Pages
- 894-905
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2050429240
- Cited by
- 310
- References
- 65
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.